Michelle A. Erickson

7.1k total citations · 4 hit papers
67 papers, 5.4k citations indexed

About

Michelle A. Erickson is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Michelle A. Erickson has authored 67 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 26 papers in Physiology and 15 papers in Molecular Biology. Recurrent topics in Michelle A. Erickson's work include Barrier Structure and Function Studies (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (22 papers) and Alzheimer's disease research and treatments (18 papers). Michelle A. Erickson is often cited by papers focused on Barrier Structure and Function Studies (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (22 papers) and Alzheimer's disease research and treatments (18 papers). Michelle A. Erickson collaborates with scholars based in United States, Japan and Slovakia. Michelle A. Erickson's co-authors include William A. Banks, Joshua B. Owen, Elizabeth M. Rhea, Aric F. Logsdon, May J. Reed, Therese S. Salameh, Yoichi Morofuji, Kim M. Hansen, Kenji Dohi and Andrej Kováč and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Neuroscience and PLoS ONE.

In The Last Decade

Michelle A. Erickson

66 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin in the brain: There and back again

2012 458 citations William A. Banks, Joshua B. Owen et al. profile →
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit

2015 451 citations William A. Banks, Michelle A. Erickson et al. Journal of Neuroinflammation profile →
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

2013 442 citations Michelle A. Erickson, William A. Banks profile →
Healthy aging and the blood–brain barrier

2021 185 citations William A. Banks, May J. Reed et al. Nature Aging profile →

Peers

Michelle A. Erickson

NEURO

PHYSI

NEURO

Qian Wang China

Servio H. Ramirez United States

Ulrich Eisel Netherlands

Peter J. Crack Australia

Barbara Viviani Italy

Gabor C. Petzold Germany

Robert M. Bryan United States

Li Tian China

Tomas Deierborg Sweden

Jonathan D. Geiger United States

Qian Wang China

Michelle A. Erickson

1.1k ×0.6

NEURO

1.2k ×0.8

PHYSI

2.2k ×1.5

744 ×0.9

NEURO

726 ×1.1

Citations per year, relative to Michelle A. Erickson Michelle A. Erickson (= 1×) peers Qian Wang

Countries citing papers authored by Michelle A. Erickson

Since Specialization

Citations

This map shows the geographic impact of Michelle A. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle A. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle A. Erickson more than expected).

Fields of papers citing papers by Michelle A. Erickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle A. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle A. Erickson. The network helps show where Michelle A. Erickson may publish in the future.

Co-authorship network of co-authors of Michelle A. Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle A. Erickson. A scholar is included among the top collaborators of Michelle A. Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle A. Erickson. Michelle A. Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erickson, Michelle A., Richard S. Johnson, Mamatha Damodarasamy, et al.. (2024). Data-independent acquisition proteomic analysis of the brain microvasculature in Alzheimer’s disease identifies major pathways of dysfunction and upregulation of cytoprotective responses. Fluids and Barriers of the CNS. 21(1). 84–84. 4 indexed citations

Banks, William A., Elizabeth M. Rhea, May J. Reed, & Michelle A. Erickson. (2024). The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications. Cell Reports Medicine. 5(11). 101760–101760. 26 indexed citations

Erickson, Michelle A., Aric F. Logsdon, Elizabeth M. Rhea, et al.. (2023). Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease. Brain Behavior and Immunity. 109. 251–268. 17 indexed citations

Banks, William A., Kim M. Hansen, Michelle A. Erickson, & Fulton T. Crews. (2023). High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally. Brain Behavior and Immunity. 111. 386–394. 15 indexed citations

Baumann, Kristen K., et al.. (2023). Effects of Ozone on Sickness and Depressive-like Behavioral and Biochemical Phenotypes and Their Regulation by Serum Amyloid A in Mice. International Journal of Molecular Sciences. 24(2). 1612–1612. 6 indexed citations

Baumann, Kristen K., Takashi Fujimoto, Lindsey Williams, et al.. (2022). Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 384(1). 205–223. 18 indexed citations

Banks, William A., et al.. (2022). Physical associations of microglia and the vascular blood-brain barrier and their importance in development, health, and disease. Current Opinion in Neurobiology. 77. 102648–102648. 16 indexed citations

Erickson, Michelle A., et al.. (2021). Interactions of SARS-CoV-2 with the Blood–Brain Barrier. International Journal of Molecular Sciences. 22(5). 2681–2681. 106 indexed citations

Banks, William A., May J. Reed, Aric F. Logsdon, Elizabeth M. Rhea, & Michelle A. Erickson. (2021). Healthy aging and the blood–brain barrier. Nature Aging. 1(3). 243–254. 185 indexed citations breakdown →

10.

Rhea, Elizabeth M., Aric F. Logsdon, William A. Banks, & Michelle A. Erickson. (2020). Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation. Pharmaceutics. 12(11). 1120–1120. 10 indexed citations

11.

Erickson, Michelle A., et al.. (2020). In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication. Fluids and Barriers of the CNS. 17(1). 26–26. 59 indexed citations

12.

Erickson, Michelle A., et al.. (2018). Genetics and sex influence peripheral and central innate immune responses and blood-brain barrier integrity. PLoS ONE. 13(10). e0205769–e0205769. 41 indexed citations

13.

Rom, Slava, Viviana Zuluaga‐Ramirez, Nancy L. Reichenbach, et al.. (2018). Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation. Journal of Neuroinflammation. 15(1). 25–25. 42 indexed citations

14.

Gannon, Patrick J., Cagla Akay, Lisa A. Briand, et al.. (2016). HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. American Journal Of Pathology. 187(1). 91–109. 29 indexed citations

15.

Erickson, Michelle A., et al.. (2012). Peripheral Administration of Antisense Oligonucleotides Targeting the Amyloid-β Protein Precursor Reverses AβPP and LRP-1 Overexpression in the Aged SAMP8 Mouse Brain. Journal of Alzheimer s Disease. 28(4). 951–960. 53 indexed citations

16.

Erickson, Michelle A., et al.. (2012). Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier. Journal of Neuroinflammation. 9(1). 150–150. 111 indexed citations

17.

Erickson, Michelle A., Kenji Dohi, & William A. Banks. (2012). Neuroinflammation: A Common Pathway in CNS Diseases as Mediated at the Blood-Brain Barrier. NeuroImmunoModulation. 19(2). 121–130. 184 indexed citations

18.

Erickson, Michelle A. & William A. Banks. (2011). Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis. Brain Behavior and Immunity. 25(8). 1637–1648. 213 indexed citations

19.

Jaeger, Laura, Shinya Dohgu, Rukhsana Sultana, et al.. (2009). Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease. Brain Behavior and Immunity. 23(4). 507–517. 224 indexed citations

20.

Banks, William A. & Michelle A. Erickson. (2009). The blood–brain barrier and immune function and dysfunction. Neurobiology of Disease. 37(1). 26–32. 406 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact